This seems like news:
Rosemont Seneca Technology Partners – an investment firm led by Hunter Biden – was a lead financial backer of Metabiota, a pandemic tracking and response firm that has partnered with Peter Daszak’s EcoHealth Alliance and the Wuhan Institute of Virology.
Rosemont Seneca Technology Partners (RSTP) was an offshoot of Rosemont Capital, an investment fund founded by Biden and John Kerry’s stepson in 2009, that counted Biden as a Managing Director.
Among the companies listed on archived versions of the firm’s portfolio is Metabiota, a San Francisco-based company that purports to detect, track, and analyze emerging infectious diseases, The National Pulse can reveal.
Financial reports reveal that RSTP led the company’s first round of funding, which amounted to $30 million. Former Managing Director and co-founder of RSTP Neil Callahan – a name that appears many times on Hunter Biden’s hard drive – also sits on Metabiota’s Board of Advisors.
Since 2014, Metabiota has been a partner of EcoHealth Alliance as part of the U.S. Agency for International Development’s (USAID) “PREDICT” project, which seeks to “predict and prevent global emerging disease threats.”
As part of this effort, researchers from Metabiota, EcoHealth Alliance, and the Wuhan Institute of Virology collaborated on a study relating to bat infectious diseases in China. “Sensitive and broadly reactive RT-PCR assays were performed at Wuhan Institute of Virology, Chinese Academy of Sciences,” the paper notes.
So Hunter Biden’s company helped fund Flu Manchu.
What are the odds?